Supramaniam Premaa, Beh Ying-Shan, Junus Suria, Devesahayam Philip Rajan
Clinical Research Centre, Hospital Raja Permaisuri Bainun, Institute for Clinical Research, National Institute of Health, Ministry of Health Malaysia, Ipoh, Perak, Malaysia.
Outpatient Pharmacy Unit, Greentown Health Clinic, Ministry of Health, Perak, Malaysia.
BMC Public Health. 2024 Dec 19;24(1):3542. doi: 10.1186/s12889-024-21056-w.
Mobile health applications (mHealth apps) offer potential benefits for improving diabetes management, such as better glucose monitoring and patient engagement, but their widespread adoption faces challenges, including privacy concerns and user adherence. This research investigates mHealth app usage among patients living with diabetes in Kinta District, Perak, exploring experiences, challenges and patient perceptions regarding diabetes management using mHealth apps.
A cross-sectional community survey was conducted in September till November 2020 across nine government health clinics focusing on diabetes mellitus (Type 1 or Type 2) patients, aged 18 years and older, receiving Diabetes Medication Adherence Counseling (DMTAC) services and able to use smart devices. A self-developed questionnaire with four sections was used to gather demographic information, explore mHealth apps usage and understand both users and non-users' experiences and perceptions. The questionnaire was tested through cognitive debriefing, translated into Malay, pre-tested and finalized by the expert committee. The questionnaire was digitally implemented using Google Form and QR code. After obtaining informed consent, data collection was performed by the trained DMTAC pharmacists. Statistical analyses involved descriptive and inferential analyses.
The study analyzed the engagement of 295 patients living with diabetes with mHealth apps. Females (54.9%), of Malay ethnicity (58.3%) and with a mean age of 53.8 years (SD: 12.38) constituted the majority. Diabetes duration had a median of 6 years (IQR: 3.0, 10.0) with prevalent comorbidities like hypertension (58.0%) and dyslipidemia (42.7%). Most patients were employed (44.7%) and their primary source of diabetes management information was through healthcare providers (92.5%). Despite the high app use for social interaction, only 13.6% used mHealth apps for disease management. Users were influenced by social media (65.0%) and favored for wellness apps and disease monitoring. Users perceived the mHealth app as useful (97.5%), yet faced challenges over the app initiation, charges and data security. Non-users cited lack of awareness (70.2%), struggled with app startup (22.4%) and preference for conventional healthcare visits (22.0%). In multivariable analysis, longer diabetes duration reduced mHealth app usage (p = 0.046), while multimorbidity increased the likelihood (p = 0.001). Awareness of the availability of health apps significantly influenced the usage of mHealth apps (p < 0.001).
The findings highlight the underutilization of mHealth apps for diabetes management despite their perceived usefulness. Challenges faced by users and non-users underscore the need for more awareness, thus encourage widespread acceptance and usage of mHealth apps in diabetes care.
移动健康应用程序(mHealth应用)为改善糖尿病管理带来了潜在益处,如更好的血糖监测和患者参与度,但它们的广泛应用面临挑战,包括隐私担忧和用户依从性问题。本研究调查了霹雳州金塔区糖尿病患者对mHealth应用的使用情况,探讨了使用mHealth应用进行糖尿病管理的体验、挑战和患者认知。
2020年9月至11月,在九个政府健康诊所开展了一项横断面社区调查,重点针对年龄在18岁及以上、接受糖尿病药物依从性咨询(DMTAC)服务且能够使用智能设备的1型或2型糖尿病患者。使用一份自行编制的包含四个部分的问卷来收集人口统计学信息,探究mHealth应用的使用情况,并了解用户和非用户的体验及认知。该问卷通过认知反馈进行测试,翻译成马来语,经专家委员会预测试并最终确定。问卷通过谷歌表单和二维码以数字方式实施。在获得知情同意后,由经过培训的DMTAC药剂师进行数据收集。统计分析包括描述性分析和推断性分析。
该研究分析了295名糖尿病患者对mHealth应用的参与情况。女性(54.9%)、马来族裔(58.3%)且平均年龄为53.8岁(标准差:12.38)的患者占大多数。糖尿病病程中位数为6年(四分位间距:3.0,10.0),常见合并症如高血压(58.0%)和血脂异常(42.7%)。大多数患者有工作(44.7%),他们获取糖尿病管理信息的主要来源是医疗服务提供者(92.5%)。尽管应用在社交互动方面使用频率很高,但只有13.6%的患者使用mHealth应用进行疾病管理。用户受到社交媒体的影响(65.0%),青睐健康应用和疾病监测功能。用户认为mHealth应用有用(97.5%),但在应用启动、费用和数据安全方面面临挑战。非用户表示缺乏认知(70.2%),在应用启动方面存在困难(22.4%),并且更倾向于传统的医疗就诊方式(22.0%)。在多变量分析中,糖尿病病程较长会降低mHealth应用的使用频率(p = 0.046),而多种合并症则会增加使用的可能性(p = 0.001)。对健康应用可用性的认知显著影响mHealth应用的使用情况(p < 0.001)。
研究结果凸显了尽管mHealth应用被认为有用,但在糖尿病管理中的利用不足。用户和非用户面临的挑战强调了提高认知的必要性,从而鼓励在糖尿病护理中广泛接受和使用mHealth应用。